540729 — Vanta Bioscience Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹164.11m
- IN₹796.33m
- IN₹19.64m
Annual cashflow statement for Vanta Bioscience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 5.89 | 2.28 | -103 | -88.3 | -126 |
| Depreciation | |||||
| Non-Cash Items | 21.2 | 23.5 | 58.9 | 57.1 | 40.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 29.1 | 13.3 | 10.8 | 13.1 | 17.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 68.7 | 52.2 | -6.28 | 26.8 | -24.1 |
| Capital Expenditures | -222 | -172 | -287 | -34 | -66.9 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | 228 | 0.915 | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -222 | -172 | -59.1 | -33.1 | -66.9 |
| Financing Cash Flow Items | -21.4 | -23.5 | -58.9 | -57.5 | -40.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 178 | 95.3 | 64.1 | 6.93 | 91.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 24.6 | -24.3 | -1.28 | 0.64 | 0.61 |